Lipoprotein(a) and apolipoprotein(a) phenotypes in patients with end-stage renal disease

Peritoneal Dialysis International

Volumn 17, Issue 3, 1997, Pages 236-242

  Kim, Soon Bae ^a   Yang, Won Seok ^a   Kang, Eun Suk ^b   Min, Won Ki ^a   Park, Jung Sik ^a  

^a University of Ulsan College of Medicine   (South Korea)

^b Asan Medical Center   (South Korea)

Author keywords

Apolipoprotein(a) phenotype; Hemodialysis; Koreans; Lipoprotein(a)

Indexed keywords

APOLIPOPROTEIN A; APOLIPOPROTEIN A1; APOLIPOPROTEIN B; CHOLESTEROL; LIPID; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SERUM ALBUMIN;

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; CONTROLLED STUDY; DIALYSIS; FEMALE; HEMODIALYSIS; HUMAN; KIDNEY FAILURE; KOREA; LIPID BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MOLECULAR WEIGHT; PHENOTYPE; PRIORITY JOURNAL;

EID: 0030842184     PISSN: 08968608     EISSN: None     Source Type: Journal    
DOI: 10.1177/089686089701700305     Document Type: Article

References (27)

1. Berg K. A new serum type system in man - the Lp system.Acta Pathol Microbiol Scand 1963; 59:369-82.
2. Gaubatz JW, Heideman C, Gotto AM Jr, Morrisett JD, Dahlen GH. Human plasma lipoprotein(a). Structural properties. J Biol Chem 1983; 258:4582-9.
3. Fless GM, ZumMallen ME, Scanu AM. Isolation of apolipoprotein(a) from lipoprotein(a). J Lipid Res 1985; 26:1224-9.
4. Bartens W, Nauck M, Schollmeyer P, Wanner C. Elevated lipoprotein(a) and fibrinogen serum levels increase the cardiovascular risk in continuous ambulatory peritoneal dialysis patients. Perit Dial Int 1996; 16:27-33
5. Kang DH, Lee SW, Rang SW, et al. Lipoprotein(a) and ischemic heart disease in patients undergoing CAPD. Kor J Nephrol 1995; 14:115-27.
6. Utermann G. The mysteries of lipoprotein(a). Science 1989; 246:904-10.
7. Shoji T, Nishizawa Y, Nishitani H, Yamakawa M, Morii H. High serum lipoprotein(a) concentrations in uremic patients treated with continuous ambulatory peritoneal dialysis. Clin Nephrol 1992; 38:271-6.
8. Hirata K, Kikuchi S, Saku K, et al. Apolipoprotein(a) phenotypes and serum lipoprotein(a) levels in maintenance hemodialysis patients with/without diabetes mellitus. Kidney Int 1993; 44:1062-70.
9. Dieplinger H, Lackner C, Kronenberg F,et al. Elevated plasma concentrations of lipoprotein(a) in patients with end-stage renal disease are not related to the size polymorphism of apolipoprotein(a). J Clin Invest 1993; 91:397-401.
10. Kronenberg F, König P, Neyer U, et al. Multicenter study of lipoprotein(a) and apolipoprotein(a) phenotypes in patients with end-stage renal disease treated by hemodialysis or continuous ambulatory peritoneal dialysis. J Am Soc Nephrol 1995; 6:110-20.
11. Bloembergen WE, Port PK, Mauger EA, Wolfe RA. A comparison of cause of death between patients treated with hemodialysis and peritoneal dialysis. J Am Soc Nephrol 1995; 6:184-91.
12. Korean Society of Nephrology, Registry Committee. Renal replacement therapy in Korea. Kor J Nephrol 1996; 15:81-24.
13. Watson PE, Watson ID, Batt RD. Total body water volumes for adult males and females estimated from simple anthropometric measurements. Am J Clin Nutr 1980; 33:27-39.
14. Daugirdas JT. Chronic hemodialysis prescription. In: Daugirdas JT, Ing TS, eds. Handbook of dialysis. Boston: Little Brown, 1994:94.
15. Friedewald WT, Levy RI, Fredrickson DS. Estimation of concentration of low density lipoprotein cholesterol in plasma without use of the ultracentrifuge. Clin Chem 1972; 18:449-502.
16. Utermann G. Lipoprotein(a). In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The metabolic and molecular bases of inherited disease. New York: McGraw-Hill, 1995:1887-912.
17. Gaw A, Boerwinkle E, Cohen JC, Hobbs HH. Comparative analysis of the apo(a) gene, apo(a) glycoprotein and plasma concentration of Lp(a) in three ethnic groups. J Clin Invest 1994; 93:2526-34.
18. s4is associated with low serum Lp(a) concentrations in Koreans. Clin Biochem 1994; 27:57-62.
19. Abe A, Noma A. Studies on apolipoprotein(a) phenotypes. Part 1. Phenotype frequencies in a healthy Japanese population. Atherosclerosis 1992; 96:1-8.
20. Maiorca R, Cancarini G. Outcome of peritoneal dialysis: comparative studies. In: Gokal R, Nolph KD, eds. The textbook of peritoneal dialysis. Dordrecht: Kluwer Academic, 1994:699-734.
21. Yang WS, Kim SB, Min WK, Park S, Lee MS, Park JS. Atherogenic lipid profile and lipoprotein(a) in relation to serum albumin in haemodialysis patients. Nephrol Dial Transplant 1995; 10:1668-71.
22. Yang WS, Kim SB, Min WK, Park JS. The effect of raising serum albumin on serum lipoprotein(a) con centration in patients on continuous ambulatory peritoneal dialysis (Abstract). J Am Soc Nephrol 1996; 7:1504.
23. Wanner C, Bartens W, Walz G, Nauck M, Schollmeyer P. Protein loss and genetic polymorphism of apolipoprotein(a) modulate serum lipoprotein(a) in CAPD patients. Nephrol Dial Transplant 1995; 10:75-81.
24. Heimbürger O, Stenvinkel P, Berglund L, Tranaeus A, Lindholm B. Increased plasma lipoprotein(a) in continuous ambulatory peritoneal dialysis is related to peritoneal transport of proteins and glucose. Nephron 1996; 72:135-44.
25. Variath R, Chan R, Michelis MF. Loss of residual renal function in hemodialysis patients is associated with decreased lipoprotein(a), a process influenced by parathyroid hormone (Abstract). J Am Soc Nephrol 1996; 7:1502.
26. Stenvinkel P, Berglund L, Ericsson S, Angelin B, Eriksson M, Alvestrand A. Low-density lipoprotein metabolism and its association to plasma Lp(a) in the nephrotic syndrome (Abstract). J Am Soc Nephrol 1996; 7:1325.
27. Kronenberg F, Utermann G, Dieplinger H. Lipoprotein(a) in renal disease. Am J Kidney Dis 1996;27:1-25.